FDA Adverse Event Malfunction Summary report: N

CASBLOOD SECONDARY SETS

MDR report key: 3172409 · Received June 5, 2013

Report

Report Number
9615050-2013-01524
Event Type
Malfunction
Date Received
June 5, 2013
Date of Event
April 1, 2013
Report Date
May 10, 2013
Manufacturer
HOSPIRA COSTA RICA LTD.
Product Code
FPA
PMA / PMN Number
K101677
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER CONTACT REPORTED THE DEVICES WERE DISCARDED. INVESTIGATION IS NOT COMPLETE. THIS REPORT REPRESENTS ALL THE INFORMATION KNOWN BY THE REPORTER UPON QUERY BY HOSPIRA PERSONNEL.

Description of Event or Problem · 1

GENERAL REPORT RECEIVED OF AN UNSPECIFIED NUMBER OF UNDOCUMENTED INCIDENTS OF DISCONNECTIONS. ON UNSPECIFIED DATED, UNSPECIFIED PRIMARY TUBING SETS WERE BEING USED TO DELIVER UNSPECIFIED MEDICATIONS, AT UNSPECIFIED RATES, VIA PUMPS. AT UNSPECIFIED LENGTHS OF TIME, THE SECURE LOCK MALE ADAPTERS OF THE SECONDARY TUBING SETS WERE CONNECTED TO FEMALE ADAPTERS AT UNSPECIFIED LOCATIONS ON THE PRIMARY TUBING SETS FOR PIGGYBACK DELIVERIES OF UNSPECIFIED VOLUMES OF UNSPECIFIED BLOOD PRODUCTS. THE CUSTOMER CONTACT REPORTED THAT AFTER THE SECONDARY DELIVERIES WERE STARTED, THE SECURE LOCKS DISCONNECTED FROM THE FEMALE ADAPTERS OF THE PRIMARY TUBING SETS. IT WAS REPORTED THAT UNSPECIFIED VOLUMES OF BLOOD PRODUCTS LEAKED. THERE WERE NO REPORTED ADVERSE PT EFFECTS AND NO REPORTED DELAYS OF THERAPIES CRITICAL TO THESE PTS. NO MEDICAL INTERVENTIONS WERE REQUIRED. THOUGH REQUESTED, NO ADDITIONAL INFORMATION WAS PROVIDED, INCLUDING IF THE TUBING SETS WERE REPLACED AND THE THERAPIES RESUMED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
249518 CASBLOOD SECONDARY SETS 80FPA FPA HOSPIRA COSTA RICA LTD. NA UNK5H

Patients

Seq Age Sex Outcome Treatment
1 UNK UNSPECIFIED PRIMARY TUBING SETS, LIST#UNK,LOT #UNK